Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population.

Dinh TA, Rosner BI, Atwood JC, Boland CR, Syngal S, Vasen HF, Gruber SB, Burt RW.

Cancer Prev Res (Phila). 2011 Jan;4(1):9-22. doi: 10.1158/1940-6207.CAPR-10-0262. Epub 2010 Nov 18.

2.

Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis.

Ladabaum U, Wang G, Terdiman J, Blanco A, Kuppermann M, Boland CR, Ford J, Elkin E, Phillips KA.

Ann Intern Med. 2011 Jul 19;155(2):69-79. doi: 10.7326/0003-4819-155-2-201107190-00002.

3.

A model-based assessment of the cost-utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients.

Snowsill T, Huxley N, Hoyle M, Jones-Hughes T, Coelho H, Cooper C, Frayling I, Hyde C.

BMC Cancer. 2015 Apr 25;15:313. doi: 10.1186/s12885-015-1254-5.

4.

A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome.

Snowsill T, Huxley N, Hoyle M, Jones-Hughes T, Coelho H, Cooper C, Frayling I, Hyde C.

Health Technol Assess. 2014 Sep;18(58):1-406. doi: 10.3310/hta18580. Review.

5.

Comparative effectiveness of screening strategies for Lynch syndrome.

Barzi A, Sadeghi S, Kattan MW, Meropol NJ.

J Natl Cancer Inst. 2015 Mar 20;107(4). pii: djv005. doi: 10.1093/jnci/djv005. Print 2015 Apr.

6.

Cost-Effectiveness Analysis of Different Genetic Testing Strategies for Lynch Syndrome in Taiwan.

Chen YE, Kao SS, Chung RH.

PLoS One. 2016 Aug 2;11(8):e0160599. doi: 10.1371/journal.pone.0160599. eCollection 2016.

7.

Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.

Bonis PA, Trikalinos TA, Chung M, Chew P, Ip S, DeVine DA, Lau J.

Evid Rep Technol Assess (Full Rep). 2007 May;(150):1-180. Review.

8.

Lynch syndrome screening strategies among newly diagnosed endometrial cancer patients.

Resnick K, Straughn JM Jr, Backes F, Hampel H, Matthews KS, Cohn DE.

Obstet Gynecol. 2009 Sep;114(3):530-6. doi: 10.1097/AOG.0b013e3181b11ecc.

PMID:
19701031
9.

Testing women with endometrial cancer to detect Lynch syndrome.

Kwon JS, Scott JL, Gilks CB, Daniels MS, Sun CC, Lu KH.

J Clin Oncol. 2011 Jun 1;29(16):2247-52. doi: 10.1200/JCO.2010.32.9979. Epub 2011 May 2.

10.

Influence of patient preferences on the cost-effectiveness of screening for Lynch syndrome.

Wang G, Kuppermann M, Kim B, Phillips KA, Ladabaum U.

Am J Manag Care. 2012 May 1;18(5):e179-85.

11.

Perceptions of cancer risks and predictors of colon and endometrial cancer screening in women undergoing genetic testing for Lynch syndrome.

Hadley DW, Jenkins JF, Steinberg SM, Liewehr D, Moller S, Martin JC, Calzone KA, Soballe PW, Kirsch IR.

J Clin Oncol. 2008 Feb 20;26(6):948-54. doi: 10.1200/JCO.2007.13.0575.

PMID:
18281669
12.

The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer.

Mvundura M, Grosse SD, Hampel H, Palomaki GE.

Genet Med. 2010 Feb;12(2):93-104. doi: 10.1097/GIM.0b013e3181cd666c.

PMID:
20084010
13.
14.

Genetic counseling and cascade genetic testing in Lynch syndrome.

Hampel H.

Fam Cancer. 2016 Jul;15(3):423-7. doi: 10.1007/s10689-016-9893-5.

PMID:
26969309
15.

Next-Generation Sequencing Panels for the Diagnosis of Colorectal Cancer and Polyposis Syndromes: A Cost-Effectiveness Analysis.

Gallego CJ, Shirts BH, Bennette CS, Guzauskas G, Amendola LM, Horike-Pyne M, Hisama FM, Pritchard CC, Grady WM, Burke W, Jarvik GP, Veenstra DL.

J Clin Oncol. 2015 Jun 20;33(18):2084-91. doi: 10.1200/JCO.2014.59.3665. Epub 2015 May 4.

16.

Fourfold increased detection of Lynch syndrome by raising age limit for tumour genetic testing from 50 to 70 years is cost-effective.

Sie AS, Mensenkamp AR, Adang EM, Ligtenberg MJ, Hoogerbrugge N.

Ann Oncol. 2014 Oct;25(10):2001-7. doi: 10.1093/annonc/mdu361. Epub 2014 Jul 31.

PMID:
25081898
17.

[Essential to discover hereditary colorectal and endometrial cancer. Mutations in "HNPCC individuals" can cause several different tumors].

Nilbert M, Grönberg H, Lindblom A.

Lakartidningen. 2002 Aug 22;99(34):3296-300. Review. Swedish.

PMID:
12362848
18.

The use of gene tests to detect hereditary predisposition to cancer: economic considerations.

Brown ML, Kessler LG.

J Natl Cancer Inst. 1995 Aug 2;87(15):1131-6.

PMID:
7674317
19.

Cost-effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome.

Kwon JS, Sun CC, Peterson SK, White KG, Daniels MS, Boyd-Rogers SG, Lu KH.

Cancer. 2008 Jul 15;113(2):326-35. doi: 10.1002/cncr.23554.

20.

Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.

Maradiegue A, Jasperson K, Edwards QT, Lowstuter K, Weitzel J.

J Am Acad Nurse Pract. 2008 Feb;20(2):76-84. doi: 10.1111/j.1745-7599.2007.00282.x. Review.

PMID:
18271762

Supplemental Content

Support Center